Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 7/20 | 0.40 |
| ▸ | ESR1 | P03372 | 4/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4223410 | 0.88 | ESR2 (0.39) | ESR2ESR1 | |
| SCHEMBL4216547 | 0.85 | TYR (0.46) | ESR2ESR1ALDH1A1GAA | |
| SCHEMBL4216531 | 0.84 | TYR (0.47) | ESR2ESR1ALDH1A1 | |
| SCHEMBL4209515 | 0.83 | TYR (0.49) | ESR2ESR1ALDH1A1 | |
| SCHEMBL4220075 | 0.83 | TYR (0.49) | ESR2ESR1ALDH1A1 | |
| SCHEMBL4220658 | 0.83 | TYR (0.49) | ESR2ESR1ALDH1A1 | |
| SCHEMBL2721166 | 0.81 | ESR2 (0.53) | ESR2ESR1 | |
| SCHEMBL2717694 | 0.80 | SHBG (0.40) | ESR2ESR1 | |
| SCHEMBL2718567 | 0.79 | ESR2 (0.41) | ESR2ESR1BACE1HSD17B1ALDH1A1 | |
| SCHEMBL4217711 | 0.79 | ESR1 (0.43) | ESR2ESR1BACE1HSD17B1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1995245-B1 | METHOD FOR PRODUCING EPOXY COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2012-05-02 | — | — | EP | disclosed |
| CN-101400665-A | Method for producing epoxy compound | SUMITOMO CHEMICAL CO (JP) | 2009-04-01 | — | — | CN | disclosed |
| US-20090054669-A1 | Process For Producing Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1995245-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054669-A1 | Process For Producing Epoxy Compound | RER1, AR, CYP1A1 | ESR2 4/4885ESR1 11/4885BACE1 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.